Search hospitals > South Dakota > Rapid City

Health Concepts

Claim this profile
Rapid City, South Dakota 57702
Global Leader in Atopic Dermatitis
Global Leader in Psoriasis
Conducts research for Osteoarthritis
Conducts research for Plaque Psoriasis
Conducts research for Medical Device Dermatitis
94 reported clinical trials
1 medical researcher
Photo of Health Concepts in Rapid CityPhoto of Health Concepts in Rapid City

Summary

Health Concepts is a medical facility located in Rapid City, South Dakota. This center is recognized for care of Atopic Dermatitis, Psoriasis, Osteoarthritis, Plaque Psoriasis, Medical Device Dermatitis and other specialties. Health Concepts is involved with conducting 94 clinical trials across 85 conditions. There are 1 research doctors associated with this hospital, such as Richard Beasley.

Top PIs

Clinical Trials running at Health Concepts

Atopic Dermatitis
Gout
Asthma
Hyperuricemia
Eczema
Alopecia Areata
Image of trial facility.

Amlitelimab

for Eczema

This is a multinational, multicenter, randomized, double-blind, placebo-controlled, parallel, Phase 3 study for treatment of participants aged 12 years and older diagnosed with moderate-to-severe atopic dermatitis (AD). The main objective of this study is to evaluate if those participants who received amlitelimab dose 1 in the parent studies (EFC17559 \[COAST-1\], EFC17560 \[COAST 2\], EFC17561 \[SHORE\]) and were responders can maintain their response either remaining at dose 1 or switching to dose 2 of amlitelimab compared to treatment withdrawal. Study details include: The study duration will be up to 68 weeks including a 52-week randomized double-blind period, and a 16-week safety follow-up for participants not entering the LTS17367 (RIVER-AD). The study duration will be up to 52 weeks for participants entering the LTS17367 \[RIVER-AD\] study at the Week 52 visit of EFC17600 (ESTUARY). The total treatment duration will be up to 52 weeks. The total number of visits will be up to 15 visits (or 14 visits for those entering LTS17367 \[RIVER-AD\] study).
Recruiting1 award Phase 33 criteria
Image of trial facility.

Amlitelimab

for Eczema

This trial is testing amlitelimab, a medication for adults with moderate to severe atopic dermatitis who were in a previous trial. The study aims to see if the medication is safe and effective over an extended time. Amlitelimab works by calming the immune system to reduce skin inflammation.
Recruiting1 award Phase 2 & 3
Image of trial facility.

Lutikizumab

for Eczema

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. The purpose of this study is to evaluate the clinical efficacy and safety of single therapies and/or combination therapies for moderate to severe AD through multiple substudies. This study will consist of multiple sub-studies, Sub-Study 1 will have a randomized, placebo controlled period 1 followed by a lutikizumab treatment period 2 enrolling 80 participants at a 1 to 1 ratio. In Sub-Study 1, participants will receive subcutaneous (SC) injections of lutikizumab or matching placebo every other week for 16 weeks followed by an additional 32 weeks of subcutaneous (SC) injections of lutikizumab every other week for a total of 52 weeks. There may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic and may require frequent medical assessments, blood tests, and biomarker collections.
Recruiting0 awards Phase 2

Similar Hospitals nearby

Frequently asked questions

What kind of research happens at Health Concepts?
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security